The estimated Net Worth of Stephen R Lee is at least $2.08 Million dollars as of 9 July 2012. Stephen Lee owns over 53,811 units of Orasure Technologies stock worth over $423,870 and over the last 19 years Stephen sold OSUR stock worth over $1,651,970.
Stephen has made over 7 trades of the Orasure Technologies stock since 2011, according to the Form 4 filled with the SEC. Most recently Stephen exercised 53,811 units of OSUR stock worth $472,999 on 9 July 2012.
The largest trade Stephen's ever made was selling 62,021 units of Orasure Technologies stock on 5 July 2012 worth over $796,970. On average, Stephen trades about 7,285 units every 13 days since 2005. As of 9 July 2012 Stephen still owns at least 99,734 units of Orasure Technologies stock.
You can see the complete history of Stephen Lee stock trades at the bottom of the page.
Stephen's mailing address filed with the SEC is 220 EAST FIRST STREET, , BETHLEHEM, PA, 18015.
Over the last 21 years, insiders at Orasure Technologies have traded over $21,897,384 worth of Orasure Technologies stock and bought 196,200 units worth $1,037,188 . The most active insiders traders include Douglas A Michels, Ronald H Spair und Michael J Gausling. On average, Orasure Technologies executives and independent directors trade stock every 43 days with the average trade being worth of $221,123. The most recent stock trade was executed by Kathleen Gallagher Weber on 19 December 2023, trading 24,129 units of OSUR stock currently worth $194,238.
based in bethlehem, pennsylvania, orasure technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. these products include tests for the detection of antibodies to the hiv virus, including the oraquick® in-home hiv test, oraquick advance® rapid hiv-1/2 antibody test and the orasure® hiv-1 oral specimen collection device, a test for antibodies to the hcv virus, the oraquick® hcv rapid antibody test, and oral fluid testing solutions for drugs of abuse testing, including intercept® oral fluid drug testing system and q.e.d.® saliva alcohol test. orasure also manufactures and sells several leading cryosurgical products. these include: histofreezer®, a product for the cryosurgical removal of common and plantar warts and several other benign skin lesions, sold to the professional or physician office market, as well as an over-the-counter product fo
Orasure Technologies executives and other stock owners filed with the SEC include: